LAURA VIVIO-KARLE: Open Payments
NPI 1063700854 · IRON MOUNTAIN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 33 payments from 9 companies in 2025. Trend: 2023 $252 · 2024 $603 · 2025 $613
Food & beverage: $613
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $236 |
| Amgen Inc. | 6 | $105 |
| E.R. Squibb & Sons, L.L.C. | 6 | $102 |
| BridgeBio Pharma, Inc. | 2 | $46 |
| PFIZER INC. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Baxter Healthcare | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: LEQVIO, Repatha, CAMZYOS, Attruby, VYNDAQEL, JARDIANCE, ELIQUIS, Hillrom - Cardiac Ambulatory Monitor.
Industry payments across MI — which companies pay providers there.
